Influence of morphine on pericyte-endothelial interaction: Implications for antiangiogenic therapy

Journal of Oncology

Volumn , Issue , 2012, Pages

  Luk, Kathryn ^a   Boatman, Sonja ^a   Johnson, Katherine N ^a   Dudek, Olivia A ^a   Ristau, Natalie ^a   Vang, Derek ^a   Nguyen, Julia ^a   Gupta, Kalpna ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE SULFATE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER GROWTH; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HORMONE RELEASE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; INTRADUCTAL CARCINOMA; MOUSE; NONHUMAN; PERICYTE; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84856490216     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/458385     Document Type: Article

References (40)

1. Hanahan D., Folkman J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 1996 86 3 353 364 (Pubitemid 26272076)
2. Siemeister G., Schirner M., Reusch P., Barleon B., Marmé D., Martiny-Baron G., An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells Proceedings of the National Academy of Sciences of the United States of America 1998 95 8 4625 4629 (Pubitemid 28207963)
3. Abdelrahim M., Konduri S., Basha M. R., Philip P. A., Baker C. H., Angiogenesis: an update and potential drug approaches (Review) International Journal of Oncology 2010 36 1 5 18
4. Carmeliet P., Jain R. K., Molecular mechanisms and clinical applications of angiogenesis Nature 2011 473 7347 298 307
5. Raza A., Franklin M. J., Dudek A. Z., Pericytes and vessel maturation during tumor angiogenesis and metastasis American Journal of Hematology 2010 85 8 593 598
6. Armulik A., Abramsson A., Betsholtz C., Endothelial/pericyte interactions Circulation Research 2005 97 6 512 523 (Pubitemid 41361741)
7. Herbert S. P., Stainier D. Y. R., Molecular control of endothelial cell behaviour during blood vessel morphogenesis Nature Reviews Molecular Cell Biology 2011 12 9 551 564
8. Helfrich I., Scheffrahn I., Bartling S., Weis J., Von Felbert V., Middleton M., Kato M., Ergn S., Schadendorf D., Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma Journal of Experimental Medicine 2010 207 3 491 503
9. Bergers G., Song S., Meyer-Morse N., Bergsland E., Hanahan D., Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors Journal of Clinical Investigation 2003 111 9 1287 1295 (Pubitemid 36554699)
10. Hughes C. C. W., Endothelial-stromal interactions in angiogenesis Current Opinion in Hematology 2008 15 3 204 209 (Pubitemid 351507572)
11. von Tell D., Armulik A., Betsholtz C., Pericytes and vascular stability Experimental Cell Research 2006 312 5 623 629 (Pubitemid 43290338)
12. Betsholtz C., Insight into the physiological functions of PDGF through genetic studies in mice Cytokine and Growth Factor Reviews 2004 15 4 215 228 (Pubitemid 38781047)
13. Ribatti D., Nico B., Crivellato E., The role of pericytes in angiogenesis International Journal of Developmental Biology 2011 55 3 261 268
14. Olson L., Soriano P., PDGFR signaling regulates mural cell plasticity and inhibits fat development Developmental Cell 2011 20 6 815 826
15. Wen H., Lu Y., Yao H., Buch S., Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability PLoS ONE 2011 6 6
16. Chen C., Farooqui M., Gupta K., Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells Current Neurovascular Research 2006 3 3 171 180 (Pubitemid 44198470)
17. Weber M. L., Farooqui M., Poonawala T., Morphine promotes renal disease in sickle mice by stimulating PDGFR-b signaling. 2011, communicated
18. Gupta K., Kshirsagar S., Chang L., Schwartz R., Law P. Y., Yee D., Hebbel R. P., Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth Cancer Research 2002 62 15 4491 4498 (Pubitemid 34827313)
19. Farooqui M., Li Y., Rogers T., Poonawala T., Griffin R. J., Song C. W., Gupta K., COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia British Journal of Cancer 2007 97 11 1523 1531 (Pubitemid 350175846)
20. Singleton P. A., Lingen M. W., Fekete M. J., Garcia J. G. N., Moss J., Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation Microvascular Research 2006 72 1-2 3 11 (Pubitemid 44118390)
21. Mathew B., Lennon F., Siegler J., Mirzapoiazova T., Mambetsariev N., Sammani S., Gerhold L. M., LaRiviere P. J., Chen C. T., Garcia J. N., Salgia R., Moss J., Singleton P. A., The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation Anesthesia Analgesia 2011 112 3 558 567
22. Fujioka N., Nguyen J., Chen C., Li Y., Pasrija T., Niehans G., Johnson K. N., Gupta V., Kratzke R. A., Gupta K., Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer Anesthesia Analgesia 2011 113 6 1353 1364
23. Madar I., Bencherif B., Lever J., Heitmiller R. F., Yang S. C., Brock M., Brahmer J., Ravert H., Dannals R., Frost J. J., Imaging -and -opioid receptors by PET in lung carcinoma patients Journal of Nuclear Medicine 2007 48 2 207 213 (Pubitemid 47555345)
24. Maroulakou I. G., Anver M., Garrett L., Green J. E., Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene Proceedings of the National Academy of Sciences of the United States of America 1994 91 23 11236 11240 (Pubitemid 24349661)
25. Bodempudi V., Ohlfest J. R., Terai K., Zamora E. A., Vogel R. I., Gupta K., Hebbel R. P., Dudek A. Z., Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors Cancer Gene Therapy 2010 17 12 855 863
26. Gupta K., Gupta P., Solovey A., Hebbel R. P., Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin Biochimica et Biophysica Acta 1999 1453 1 63 73 (Pubitemid 29065458)
27. McQuay H. J., Carroll D., Faura C. C., Gavaghan D. J., Hand C. W., Moore R. A., Oral morphine in cancer pain: influences on morphine and metabolite concentration Clinical Pharmacology and Therapeutics 1990 48 3 236 244 (Pubitemid 20323649)
28. Klepstad P., Kaasa S., Borchgrevink P. C., Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine European Journal of Clinical Pharmacology 2000 55 10 713 719 (Pubitemid 30077565)
29. Dai X., Song H. J., Cui S. G., Wang T., Liu Q., Wang R., The stimulative effects of endogenous opioids on endothelial cell proliferation, migration and angiogenesis in vitro European Journal of Pharmacology 2010 628 13 42 50
30. Singleton P. A., Moss J., Effect of perioperative opioids on cancer recurrence: a hypothesis Future Oncology 2010 6 8 1237 1242
31. Boehncke S., Hardt K., Schadendorf D., Henschler R., Boehncke W. H., Duthey B., Endogenous -opioid peptides modulate immune response towards malignant melanoma Experimental Dermatology 2011 20 1 24 28
32. Heldin C. H., Westermark B., Mechanism of action and in vivo role of platelet-derived growth factor Physiological Reviews 1999 79 4 1283 1316 (Pubitemid 29473317)
33. Tallquist M. D., French W. J., Soriano P., Additive effects of PDGF receptor signaling pathways in vascular smooth muscle cell development PLoS Biology 2003 1 2
34. Nehls V., Drenckhahn D., The versatility of microvascular pericytes: from mesenchyme to smooth muscle? Histochemistry 1993 99 1 1 12 (Pubitemid 23058525)
35. Morikawa S., Baluk P., Kaidoh T., Haskell A., Jain R. K., M D. M., Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors American Journal of Pathology 2002 160 3 985 1000 (Pubitemid 34224587)
36. Hellstrm M., Kalén M., Lindahl P., Abramsson A., Betsholtz C., Role of PDGF-B and PDGFR- in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse Development 1999 126 14 3047 3055 (Pubitemid 29378170)
37. Kitadai Y., Sasaki T., Kuwai T., Nakamura T., Bucana C. D., Hamilton S. R., Fidler I. J., Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential International Journal of Cancer 2006 119 11 2567 2574 (Pubitemid 44691309)
38. Donahue R. N., McLaughlin P. J., Zagon I. S., The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice Gynecologic Oncology 2011 122 2 382 388
39. Donahue R. N., McLaughlin P. J., Zagon I. S., Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin Experimental Biology and Medicine 2011 236 7 883 895
40. Berkson B. M., Rubin D. M., Berkson A. J., Revisiting the ALA/N ( -Lipoic Acid/Low-Dose Naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases Integrative Cancer Therapies 2009 8 4 416 422